CYP1A1 inhibitor 8a
CYP1A1 inhibitor 8a is a compound that potently and selectively inhibits the CYP1A1 enzyme and has the potential to prevent cancer. CYP1A1 inhibitor 8a exhibits more than 10-fold selectivity for CYP1A1 and more than 100-fold selectivity over other enzymes in the CYP1 subfamily. CYP1A1 inhibitor 8a can effectively antagonize B[a]P-mediated activation of the aryl hydrocarbon receptor (AhR) in yeast cells and protect human cells from CYP1A1-mediated B[a]P toxicity. CYP1A1 inhibitor 8a has the potential to be developed as a cancer chemopreventive agent[1].
Product Specifications
CAS Number
1821136-07-5
UNSPSC
12352005
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cyp1a1-inhibitor-8a.html
Smiles
O=C(C1=CC=NC=C1)/C=C/C2=CC(OC)=C(OC)C(OC)=C2
Molecular Formula
C17H17NO4
Molecular Weight
299.32
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
IgA Secretory Component (SC05), CF640R conjugate, 0.1mg/mL
Eosinophil Peroxidase (AHE-1), CF594 conjugate, 0.1mg/mL
Neurofilament (NF-H) (Neuronal Marker) (NEFL.H/2324R), CF647 conjugate, 0.1mg/mL
